Impact of methicillin-resistant Staphylococcus aureus infection on morbidity and costs in healthcare facilities [1]

Infection Control and Hospital Epidemiology

Volumn 27, Issue 9, 2006, Pages 994-995

  Verbrugh, Henri A ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BACTEREMIA; BACTERIAL INFECTION; BLOOD CULTURE; ENDEMIC DISEASE; HEALTH CARE COST; HEALTH CARE FACILITY; HOSPITAL ADMISSION; HOSPITAL INFECTION; HOSPITALIZATION; LETTER; MEDICAL RESEARCH; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORBIDITY; PUBLICATION;

HEALTH FACILITIES; HUMANS; METHICILLIN RESISTANCE; STAPHYLOCOCCAL INFECTIONS;

EID: 33749005687     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/507291     Document Type: Letter

References (5)

1. Cosgrove SE, Qi Y, Kaye KS, et al. The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges. Infect Control Hosp Epidemiol 2005; 26:166-174.
2. Reed SD, Friedman JY, Engemann JJ, et al. Costs and outcomes among hemodialysis-dependent patients with methicillin-resistant or methicillin-susceptible Staphylococcus aureus bacteremia. Infect Control Hosp Epidemiol 2005; 26:175-183.
3. Vos MC, Verbrugh HA. MRSA: we can overcome, but who will lead the battle? Infect Control Hosp Epidemiol 2005; 26:117-120.
4. Haley RW, Schaberg DR, Von Allmen SD, McGowan JE Jr. Estimating the extra charges and prolongation of hospitalization due to nosocomial infections: a comparison of methods. J Infect Dis 1980; 141:248-257.
5. Kim T, Oh PI, Simor AE. The economic impact of methicillin-resistant Staphylococcus aureus in Canadian hospitals. Infect Control Hosp Epidemiol 2001; 22:99-104.